Pär Stattin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Locally Advanced

Radical Prostatectomy

Prostate Cancer

Mild Cognitive Impairment

Top Venues

BJU international

Journal of the National Cancer Institute

Scandinavian journal of urology

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Casey Crump, Pär Stattin, James D Brooks, Jan Sundquist, Alexis C Edwards, Kristina Sundquist, Weiva Sieh
Response to Lao, Guan, Wang, et al. Journal of the National Cancer Institute 116 (5) (2024)
Casey Crump, Pär Stattin, James D Brooks, Jan Sundquist, Alexis C Edwards, Kristina Sundquist, Weiva Sieh
Response to Lao, Guan, Wang, et al. Journal of the National Cancer Institute 116 (5) (2024)
Pär Stattin, Sarah Fleming, Xiwu Lin, Florence Lefresne, Sabine D Brookman-May, Suneel D Mundle, Helen Pai, Dina Gifkins, David L Robinson, Johan Styrke, Hans Garmo
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer. BJU international 134 (1) (2024)
Casey Crump, Pär Stattin, James D Brooks, Jan Sundquist, Alexis C Edwards, Kristina Sundquist, Weiva Sieh
Response to Lao, Guan, Wang, et al. Journal of the National Cancer Institute 116 (5) (2024)
Casey Crump, Pär Stattin, James D Brooks, Jan Sundquist, Alexis C Edwards, Kristina Sundquist, Weiva Sieh
Response to Lao, Guan, Wang, et al. Journal of the National Cancer Institute 116 (5) (2024)
Pär Stattin, Sarah Fleming, Xiwu Lin, Florence Lefresne, Sabine D Brookman-May, Suneel D Mundle, Helen Pai, Dina Gifkins, David L Robinson, Johan Styrke, Hans Garmo
Population-based study of disease trajectory after radical treatment for high-risk prostate cancer. BJU international (2024)
Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Xabier Garcia de Albeniz, Pär Stattin, Marcus Westerberg, Rachel Weinrib, Per Sandstrom, Zdravko Vassilev
Design considerations for observational studies of drugs for advanced cancer. Pharmacoepidemiology and drug safety (2023)
Karin Braide, Jon Kindblom, Camilla Thellenberg Karlsson, Pär Stattin, Jonas Hugosson, Marianne Månsson
Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study. BJU international 130 (6) (2022)
Andri Wilberg Orrason, Johan Styrke, Hans Garmo, Pär Stattin
Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden. BJU international (2022)
Andri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, Johan Styrke, David L Robinson, Hans Garmo, Pär Stattin
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy. PloS one 17 (11) (2022)
Eleanor L Watts, Aurora Perez-Cornago, Georgina K Fensom, Karl Smith-Byrne, Urwah Noor, Colm D Andrews, Marc J Gunter, Michael V Holmes, Richard M Martin, Konstantinos K Tsilidis, Demetrius Albanes, Aurelio Barricarte, H Bas Bueno-de-Mesquita, Barbara A Cohn, Melanie Deschasaux-Tanguy, Niki L Dimou, Luigi Ferrucci, Leon Flicker, Neal D Freedman, Graham G Giles, Edward L Giovannucci, Christopher A Haiman, Graham J Hankey, Jeffrey M P Holly, Jiaqi Huang, Wen-Yi Huang, Lauren M Hurwitz, Rudolf Kaaks, Tatsuhiko Kubo, Loic Le Marchand, Robert J MacInnis, Satu Männistö, E Jeffrey Metter, Kazuya Mikami, Lorelei A Mucci, Anja W Olsen, Kotaro Ozasa, Domenico Palli, Kathryn L Penney, Elizabeth A Platz, Michael N Pollak, Monique J Roobol, Catherine A Schaefer, Jeannette M Schenk, Pär Stattin, Akiko Tamakoshi, Elin Thysell, Chiaojung Jillian Tsai, Mathilde Touvier, Stephen K Van Den Eeden, Elisabete Weiderpass, Stephanie J Weinstein, Lynne R Wilkens, Bu B Yeap, null null, Naomi E Allen, Timothy J Key, Ruth C Travis
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. International journal of epidemiology (2022)
Rolf Gedeborg, Johan Styrke, Stacy Loeb, Hans Garmo, Pär Stattin
Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic. PloS one 16 (10) (2021)
Giuseppe Fallara, Fredrik Sandin, Johan Styrke, Stefan Carlsson, Ingela Franck Lissbrant, Johan Ahlgren, Ola Bratt, Mats Lambe, Pär Stattin
Prostate cancer diagnosis, staging, and treatment in Sweden during the first phase of the COVID-19 pandemic. Scandinavian journal of urology 55 (3) (2021)
Johan Björklund, Pär Stattin, Erik Rönmark, Markus Aly, Olof Akre
The 90-day cause-specific mortality after radical prostatectomy: a nationwide population-based study. BJU international (2021)
Kerri Beckmann, Hans Garmo, Ingela Franck Lissbrant, Pär Stattin
The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries. Cancers 13 (4) (2021)
Lars Egevad, Brett Delahunt, David G Bostwick, Liang Cheng, Andrew J Evans, Troy Gianduzzo, Markus Graefen, Jonas Hugosson, James G Kench, Katia R M Leite, Jon D Oxley, Guido Sauter, John R Srigley, Pär Stattin, Toyonori Tsuzuki, John Yaxley, Hemamali Samaratunga
Prostate cancer grading, time to go back to the future. BJU international 127 (2) (2020)
Andri Wilberg Orrason, Marcus Westerberg, Hans Garmo, Ingela Franck Lissbrant, David L Robinson, Pär Stattin
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden. BJU international 126 (1) (2020)
Andreas Pettersson, Daniel Alm, Hans Garmo, Marie Hjelm Eriksson, Enrique Castellanos, Lennart Åström, Jon Kindblom, Anders Widmark, Adalsteinn Gunnlaugsson, Ingela Franck Lissbrant, Per Nilsson, Pär Stattin
Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study. JNCI cancer spectrum 4 (2) (2020)
Ola Bratt, Linda Drevin, Karl-Göran Prütz, Stefan Carlsson, Lars Wennberg, Pär Stattin
Prostate cancer in kidney transplant recipients - a nationwide register study. BJU international 125 (5) (2020)
Johanna Svensson, Ingela Franck Lissbrant, Oskar Gauffin, Marie Hjälm-Eriksson, Suzanne Kilany, Karin Fagerlund, Pär Stattin
Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden. Scandinavian journal of urology 55 (1) (2020)
David L Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan-Erik Damber, Ola Bratt, Lars Holmberg, Lars-Olof Wahlund, Pär Stattin, Jan Adolfsson
Androgen deprivation therapy for prostate cancer and risk of dementia. BJU international 124 (1) (2019)
Marcus Westerberg, Ingela Franck Lissbrant, Jan Erik Damber, David Robinson, Hans Garmo, Pär Stattin
Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study. Acta oncologica (Stockholm, Sweden) 59 (1) (2019)
Walter Cazzaniga, Hans Garmo, David L Robinson, Lars Holmberg, Anna Bill-Axelson, Pär Stattin
Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study. BJU international 123 (3) (2018)
Pär Stattin, Fredrik Sandin, Stacy Loeb, David Robinson, Ingela Franck Lissbrant, Mats Lambe
Public online reporting from a nationwide population-based clinical prostate cancer register. BJU international 122 (1) (2018)